Numaferm raises €1.5M Seed round
11 May 2017· Düsseldorf, Germany· health, biotech, materials, b2b, deep_hardware
The funding was used for the further technological development of the Numaferm platform and for an accelerated market entry of their peptide production technology.
Investors
LeadHigh-Tech Gründerfonds
Also participating
European Investment FundDetlev RiesnerJürgen SchumacherEvonik Venture Capital
About Numaferm
Stage
Pre-Seed
Headquarters
Düsseldorf, Germany
Founded
2017
Team Size
21–50
Sectors
healthbiotechmaterialsb2bdeep_hardware